Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine screening for sexual dysfunction using free testosterone determinations

F E Govier1, R D McClure, D Kramer-Levien

  • 1Virginia Mason Medical Center, Seattle, Washington, USA.

The Journal of Urology
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of hyperparathyroidism treatment.

Anales de cirugia·2010
Same author

The present status of iodized salt.

Journal - Michigan State Medical Society·2010
Same author

Intravenous Pectin Solution in the Prophylaxis and Treatment of Shock.

Canadian Medical Association journal·2010
Same author

Management of Breast Tumours.

Canadian Medical Association journal·2010
Same author

Tumors of the female breast; a diagnostic and therapeutic summary.

Journal - Michigan State Medical Society·2010
Same author

Surgical treatment of bleeding peptic ulcer.

The Ohio State medical journal·2010
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Routine endocrine screening is essential for men with sexual dysfunction. Measuring free testosterone levels can reduce unnecessary tests by 50%, aiding in hypogonadism diagnosis.

Area of Science:

  • Endocrinology
  • Urology
  • Sexual Medicine

Background:

  • The necessity of routine endocrine screening in impotent men is debated.
  • Optimal hormonal studies, including the role of free testosterone, are unclear.
  • Predictive value of decreased libido or testicular atrophy for endocrinopathies is uncertain.

Purpose of the Study:

  • To evaluate the necessity of routine endocrine screening in men with sexual dysfunction.
  • To determine the most effective hormonal tests for diagnosing endocrinopathies.
  • To assess the utility of free testosterone measurements and clinical signs in predicting hypogonadism.

Main Methods:

  • Retrospective review of 508 men with sexual dysfunction over 22 months.
  • Analysis of available testosterone and prolactin data for a subset of patients.

Related Experiment Videos

  • Definition of hypogonadism based on two abnormal total testosterone levels.

    • Main Results:

    • Hypogonadism was diagnosed in 15.6% of patients with available testosterone data.
    • Decreased libido or testicular atrophy did not reliably predict hypogonadism.
    • Normal free testosterone levels averted further evaluation in 50% of hypogonadal men.
    • Hypoprolactinemia was found in 1.8% of patients.

    Conclusions:

    • Routine endocrine screening is necessary for evaluating sexual dysfunction.
    • Clinical signs like decreased libido or testicular atrophy are poor predictors of hypogonadism.
    • Measuring free testosterone levels is recommended to reduce unnecessary endocrine testing.
    • Prolactin level measurement is indicated only for specific patient subgroups.